-+ 0.00%
-+ 0.00%
-+ 0.00%

CORCEPT PRESENTS RESULTS FROM PHASE 2 STUDY OF DAZUCORILANT IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) AT ENCALS 2025 ANNUAL MEETING

Reuters·06/05/2025 10:00:00

Please log in to view news